
Lane 1: Mouse Liver cell lysates probed with Calreticulin Polyclonal Antibody, Unconjugated (bs-5913R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Calreticulin Polyclonal Antibody
BS-5913R
ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetCALR
Overview
- SupplierBioss
- Product NameCalreticulin Polyclonal Antibody
- Delivery Days Customer16
- ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
- Applications SupplierWB(1:300-5000), ELISA(1:500-1000), FCM(1:20-100), IHC-P(1:200-400), IHC-F(1:100-500), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 ug/ul
- ConjugateUnconjugated
- Gene ID811
- Target nameCALR
- Target descriptioncalreticulin
- Target synonymsCALR1, CRT, HEL-S-99n, RO, SSA, cC1qR, calreticulin, CRP55, ERp60, HACBP, Sicca syndrome antigen A (autoantigen Ro; calreticulin), calregulin, endoplasmic reticulum resident protein 60, epididymis secretory sperm binding protein Li 99n, grp60
- HostRabbit
- IsotypeIgG
- Protein IDP27797
- Protein NameCalreticulin
- Storage Instruction-20°C
- UNSPSC12352203
References
- Tanaka M, Kataoka H, Yano S, et al. Immunogenic cell death due to a new photodynamic therapy (PDT) with glycoconjugated chlorin (G-chlorin). Oncotarget. 2016,7(30):47242-47251. doi: 10.18632/oncotarget.9725Read this paper
- Chen B, Wu Z, Xu J, et al. Calreticulin Binds to Fas Ligand and Inhibits Neuronal Cell Apoptosis Induced by Ischemia-Reperfusion Injury. Biomed Res Int. 2015,2015:895284. doi: 10.1155/2015/895284Read this paper
- Erbas O, Anil Korkmaz H, Oltulu F, et al. Oxytocin alleviates cisplatin-induced renal damage in rats. Iran J Basic Med Sci. 2014,17(10):747-52.Read this paper









